TNFRSF10A antibody
Quick Overview for TNFRSF10A antibody (ABIN1959968)
Target
See all TNFRSF10A AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- Monoclonal antibody DR-4-02 recognizes TRAIL-R1 (DR4), a human death receptor 4 (468 amino acids) expressed in most human tissues (spleen, peripheral blood leucocytes, thymus) and in a variety of tumor-derived cell lines.
-
Purification
- Protein A purified
-
Immunogen
-
Fusion protein containing the extracellular part of TRAIL-R1 and the constant part of the heavy chain of the human IgG1.
Type of Immunogen: Fusion protein -
Isotype
- IgG1
-
-
-
-
Application Notes
-
Approved: Block, Flo, Func, ICC, IP, Neut
Usage: Flow Cytometry: Recommended dilution - 3-5 μg/mL. Functional Application: Soluble antibody DR-4-02 blocks apoptosis triggered by a ligand (TRAIL). Plastic-immobilized (cross-linked) DR-4-02 antibody induces apoptosis in sensitive cells. Recommended diluti -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 15 mM sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Do not freeze.
-
Storage
- 4 °C
-
Storage Comment
- Store at 2-8°C. Do not freeze.
-
-
- TNFRSF10A (Tumor Necrosis Factor Receptor Superfamily, Member 10a (TNFRSF10A))
-
Alternative Name
- TNFRSF10A / DR4
-
Background
-
Name/Gene ID: TNFRSF10A
Family: TNF Receptor
Synonyms: TNFRSF10A, APO2, CD261, DR4, TRAIL-R1, TRAILR-1, TRAILR1, TRAIL receptor 1, CD261 antigen, Cytotoxic TRAIL receptor, Death receptor 4 -
Gene ID
- 8797
-
Pathways
- Apoptosis, Positive Regulation of Endopeptidase Activity
Target
-